To further explore the role of activated STAT3 in esophageal cancers, 8 different ESCC cell lines were examined by immunoblotting using the anti-STAT3 and anti-phosphorylated STAT3 (Tyr-705) antibodies. This evidence concerns the gene STAT3 and esophageal squamous cell carcinoma.